<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>2</IssueIDStart>
          <IssueIDEnd>2</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>6</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art4">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>72281</ArticleID>
            <ArticleDOI>10.1208/aapsj070229</ArticleDOI>
            <ArticleSequenceNumber>4</ArticleSequenceNumber>
            <ArticleTitle Language="En">Drug compounding for veterinary patients</ArticleTitle>
            <ArticleFirstPage>E281</ArticleFirstPage>
            <ArticleLastPage>E287</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>9</Month>
                <Day>23</Day>
              </Received>
              <Accepted>
                <Year>2004</Year>
                <Month>9</Month>
                <Day>27</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>2</IssueIDStart>
              <IssueIDEnd>2</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mark</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>Papich</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(919) 513-6221</Phone>
                  <Fax>(919) 513-6465</Fax>
                  <Email>mark_papich@ncsu.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Diplomate American College of Veterinary Clinical Pharmacology, North Corolina State University</OrgDivision>
                <OrgName>College of Veterinary Medicine</OrgName>
                <OrgAddress>
                  <Street>4700 Hillsborough Street</Street>
                  <Postcode>27606</Postcode>
                  <City>Raleigh</City>
                  <State>NC</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Drugs have been compounded for veterinary practice for many years because it has been necessary in the course of routine practice. However, regulations and compliance policy guidelines (CPGs) should be recognized. A new CPG issued in July 2003 listed the current Food and Drug Administration (FDA) limitations on compounding for veterinary medicine. To summarize the guideline: drugs must not be compounded from bulk substances, and the compounding must not constitute, manufacture of a new animal drug. Drug compounding on a case-by-case basis is allowed under the CPG. However, veterinarians and pharmacists must be aware of potential incompatibilities and practices that may interfere with the drug's stability, purity, and/or potency.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>compounding</Keyword>
              <Keyword>veterinary drugs</Keyword>
              <Keyword>
                <Emphasis Type="Italic">USP</Emphasis>
              </Keyword>
              <Keyword>extralabel drug use</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: September 22, 2005.</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_72281.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibChapter>
                  <InstitutionalAuthorName>United States Pharmacopeial Convention</InstitutionalAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Good compounding practices</ChapterTitle>
                  <BookTitle>The United States Pharmacopeia and the National Formulary, USP 28, NF 23</BookTitle>
                  <PublisherName>United States Pharmacopeial Convention, Inc</PublisherName>
                  <PublisherLocation>Rockville, MD</PublisherLocation>
                  <FirstPage>2620</FirstPage>
                  <LastPage>2457</LastPage>
                </BibChapter>
                <BibUnstructured>United States Pharmacopeial Convention. Good compounding practices. In:<Emphasis Type="Italic">The United States Pharmacopeia and the National Formulary, USP 28, NF 23</Emphasis>. Rockville, MD: United States Pharmacopeial Convention, Inc; 2005:2620–2457.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <InstitutionalAuthorName>FDA-CVM</InstitutionalAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">FDA/CVM's Compliance policy guide on compounding of drugs</ArticleTitle>
                  <JournalTitle>J. Am Vet Med Assoc.</JournalTitle>
                  <VolumeID>209</VolumeID>
                  <FirstPage>2025</FirstPage>
                  <LastPage>2029</LastPage>
                </BibArticle>
                <BibUnstructured>FDA-CVM. FDA/CVM's Compliance policy guide on compounding of drugs.<Emphasis Type="Italic">J. Am Vet Med Assoc.</Emphasis> 1996;209:2025–2029.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibUnstructured>Symposium on Compounding in Veterinary Medicine.<Emphasis Type="Italic">J Am Vet Med Assoc.</Emphasis> 1993;205:189–303.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibUnstructured>FDA-CVM. Food and Drug Administration Web site. Compounding of Drugs for Use in Animals. Compliance Policy Guide: Compliance Policy Guidance for FDA Staff and Industry. Ch 6, sub ch 600, §608.400. Available at: http://www.fda.gov/cvm/index/updates/compound.htm. Accessed July 2003.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <InstitutionalAuthorName>JAVMA</InstitutionalAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Animal drugs seized</ArticleTitle>
                  <JournalTitle>J Am Vet Med Assoc</JournalTitle>
                  <VolumeID>214</VolumeID>
                  <FirstPage>21</FirstPage>
                  <LastPage>21</LastPage>
                </BibArticle>
                <BibUnstructured>JAVMA. Animal drugs seized.<Emphasis Type="Italic">J Am Vet Med Assoc</Emphasis>. 1999;214:21.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Compounding for creatures: what works</ArticleTitle>
                  <JournalTitle>Int J Pharm Comp</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>182</FirstPage>
                  <LastPage>187</LastPage>
                </BibArticle>
                <BibUnstructured>Davis J. Compounding for creatures: what works.<Emphasis Type="Italic">Int J Pharm Comp</Emphasis>. 1999;3:182–187.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Graham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lipman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Newell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GD</Initials>
                    <FamilyName>Roberts</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Esophageal transit of capsules in clinically normal cats</ArticleTitle>
                  <JournalTitle>Am J Vet Res.</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>655</FirstPage>
                  <LastPage>657</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10850841</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2460/ajvr.2000.61.655</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3cvpvFWisw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Graham JP, Lipman AH, Newell SM, Roberts GD. Esophageal transit of capsules in clinically normal cats.<Emphasis Type="Italic">Am J Vet Res.</Emphasis> 2000;61:655–657.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DS</Initials>
                    <FamilyName>Westfall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Twedt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PF.</Initials>
                    <FamilyName>Steyn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EB</Initials>
                    <FamilyName>Oberhauser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>VanCleave</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Evaluation of esophageal transit of tablets and capsules in 30 cats</ArticleTitle>
                  <JournalTitle>J Vet Intern Med.</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>467</FirstPage>
                  <LastPage>470</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11596734</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1892/0891-6640(2001)015&lt;0467:EOETOT&gt;2.3.CO;2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MrltVCmsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Westfall DS, Twedt DC, Steyn PF., Oberhauser EB, VanCleave JW. Evaluation of esophageal transit of tablets and capsules in 30 cats.<Emphasis Type="Italic">J Vet Intern Med.</Emphasis> 2001;15:467–470.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Carlborg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Densert</FamilyName>
                  </BibAuthorName>
                  <Year>1980</Year>
                  <ArticleTitle Language="En">Esophageal lesions caused by orally administered drugs: an experimental study in the cat</ArticleTitle>
                  <JournalTitle>Eur Surg Res.</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>270</FirstPage>
                  <LastPage>282</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7250155</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3MXhtFCisbs%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1159/000128132</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Carlborg B, Densert O. Esophageal lesions caused by orally administered drugs: an experimental study in the cat.<Emphasis Type="Italic">Eur Surg Res.</Emphasis> 1980;12:270–282.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Carlborg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Densert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lindqvist</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">Tetracycline induced esophagcal ulcers: a clinical and experimental study</ArticleTitle>
                  <JournalTitle>Laryngoscope</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>184</FirstPage>
                  <LastPage>187</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6823189</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3sXhsFCqsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carlborg B, Densert O, Lindqvist C. Tetracycline induced esophagcal ulcers: a clinical and experimental study.<Emphasis Type="Italic">Laryngoscope</Emphasis>. 1983;93:184–187.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibChapter>
                  <InstitutionalAuthorName>United States Pharmacopeial Convention</InstitutionalAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Stability considerations in dispensing practice</ChapterTitle>
                  <BookTitle>The United States Pharmacopeia and the National Formulary, USP 28, NF 23</BookTitle>
                  <PublisherName>United States Pharmacopeial Convention, Inc</PublisherName>
                  <PublisherLocation>Rockville, MD</PublisherLocation>
                  <FirstPage>2727</FirstPage>
                  <LastPage>2730</LastPage>
                </BibChapter>
                <BibUnstructured>United States Pharmacopeial Convention. Stability considerations in dispensing practice. In:<Emphasis Type="Italic">The United States Pharmacopeia and the National Formulary, USP 28, NF 23</Emphasis>. Rockville, MD: United States Pharmacopeial Convention, Inc; 2005:2727–2730.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Nieto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Spier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FS</Initials>
                    <FamilyName>Pipers</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training</ArticleTitle>
                  <JournalTitle>J Am Vet Med Assoc</JournalTitle>
                  <VolumeID>221</VolumeID>
                  <FirstPage>1139</FirstPage>
                  <LastPage>1143</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12387383</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2460/javma.2002.221.1139</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosFSru78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nieto JE, Spier S, Pipers FS, et al., Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.<Emphasis Type="Italic">J Am Vet Med Assoc</Emphasis>, 2002;221:1139–1143.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GM</Initials>
                    <FamilyName>Grass</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Sinko</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Physiologically-based pharmacokinetic simulation modelling</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>433</FirstPage>
                  <LastPage>451</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11922957</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(02)00013-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xitlaruro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grass GM, Sinko PJ. Physiologically-based pharmacokinetic simulation modelling.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2002;54:433–451.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Martinez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Amidon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Clarke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WW</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Mitra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Riviere</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev.</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>825</FirstPage>
                  <LastPage>850</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12363433</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(02)00071-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnsVSjtrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martinez M, Amidon G, Clarke L, Jones WW, Mitra A, Riviere J. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2002;54:825–850.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Martinez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Augsburger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Johnston</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WW</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I. Biopharmaceutics and formulation considerations</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev.</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>805</FirstPage>
                  <LastPage>824</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12363432</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(02)00070-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnsVSjtrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martinez M, Augsburger L, Johnston T, Jones WW. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I. Biopharmaceutics and formulation considerations.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2002:54:805–824.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Amidon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lennernas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Shah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Crison</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">A theoretical basis for a biopharmaceutics drug classification: the correlation of<Emphasis Type="Italic">in vitro</Emphasis> drug product dissolution and<Emphasis Type="Italic">in vivo</Emphasis> bioavailability</ArticleTitle>
                  <JournalTitle>Pharm Res.</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>413</FirstPage>
                  <LastPage>420</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7617530</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1016212804288</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXksVGqur8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of<Emphasis Type="Italic">in vitro</Emphasis> drug product dissolution and<Emphasis Type="Italic">in vivo</Emphasis> bioavailability.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1995;12:413–420.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TT</Initials>
                    <FamilyName>Kararli</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals</ArticleTitle>
                  <JournalTitle>Biopharm Drug Dispos</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>351</FirstPage>
                  <LastPage>380</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8527686</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/bdd.2510160502</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXmvFOls70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.<Emphasis Type="Italic">Biopharm Drug Dispos</Emphasis>. 1995;16:351–380.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Dressman</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Comparison of canine and human gastrointestinal physiology</ArticleTitle>
                  <JournalTitle>Pharm Res.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>123</FirstPage>
                  <LastPage>131</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1016353705970</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XltVagu7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dressman JB. Comparison of canine and human gastrointestinal physiology.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1986;3:123–131.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Species similarities and differences in pharmacokinetics</ArticleTitle>
                  <JournalTitle>Drug Metab Dispos</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>1008</FirstPage>
                  <LastPage>1021</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8654187</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXovFGksbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lin JH. Species similarities and differences in pharmacokinetics.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1995;23:1008–1021.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WL</Initials>
                    <FamilyName>Chiou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HY</Initials>
                    <FamilyName>Jeong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Chung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TC</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>135</FirstPage>
                  <LastPage>140</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10751026</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1007552927404</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXitVOqtbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chiou WL, Jeong HY, Chung SM, Wu TC. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2000;17:135–140.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Sabnis</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Factors influencing the bioavailability of peroral formulations of drugs for dogs</ArticleTitle>
                  <JournalTitle>Vet Res Commun</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>425</FirstPage>
                  <LastPage>447</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10598074</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1006321625243</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c%2FmsV2ntg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sabnis S. Factors influencing the bioavailability of peroral formulations of drugs for dogs.<Emphasis Type="Italic">Vet Res Commun</Emphasis>. 1999;23:425–447.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Papich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Hardie</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats</ArticleTitle>
                  <JournalTitle>Am J Vet Res.</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>672</FirstPage>
                  <LastPage>677</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10850844</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2460/ajvr.2000.61.672</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXksF2qtrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lee DD, Papich MG, Hardie EM. Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats.<Emphasis Type="Italic">Am J Vet Res.</Emphasis> 2000;61:672–677.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Kyles</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Papich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Hardie</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Disposition of transdermally administered fentanyl in dogs</ArticleTitle>
                  <JournalTitle>Am J Vet Res</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>715</FirstPage>
                  <LastPage>719</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8723888</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xjtlequrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kyles AE, Papich MG, Hardie EM. Disposition of transdermally administered fentanyl in dogs.<Emphasis Type="Italic">Am J Vet Res</Emphasis>. 1996;57:715–719.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Kyles</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Hardie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BD</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Papich</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs</ArticleTitle>
                  <JournalTitle>Res Vet Sci</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>245</FirstPage>
                  <LastPage>251</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9915151</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0034-5288(98)90151-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhtVejs70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kyles AE, Hardie EM, Hansen BD, Papich MG Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs.<Emphasis Type="Italic">Res Vet Sci</Emphasis>. 1998;65:245–251.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Riviere</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Papich</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Potential, and problems of developing transdermal patches for veterinary applications</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>175</FirstPage>
                  <LastPage>203</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11500227</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00157-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlslChtr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Riviere JE, Papich MG. Potential, and problems of developing transdermal patches for veterinary applications.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;50:175–203.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Nolan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Davidson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Webster</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <BookTitle>Pharmacokinetics of transdermal diltiazem in cats [abstract 25]</BookTitle>
                  <SeriesTitle Language="En">Paper presented at: North Carolina State Research Forum</SeriesTitle>
                  <PublisherName>North Carolina State University</PublisherName>
                  <PublisherLocation>Raleigh, NC</PublisherLocation>
                </BibBook>
                <BibUnstructured>Nolan TR, Davidson G, Webster K, Pharmacokinetics of transdermal diltiazem in cats [abstract 25]. Paper presented at: North Carolina State Research Forum; May 2002; North Carolina State University, Raleigh, NC.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Yoder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Trepanier</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats</ArticleTitle>
                  <JournalTitle>J Vet Pharmacol Therap</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>189</FirstPage>
                  <LastPage>193</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-2885.2002.00405.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlvFyku7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.<Emphasis Type="Italic">J Vet Pharmacol Therap</Emphasis>. 2002;25:189–193.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Papich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hoenig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Fettman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Lappin</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats</ArticleTitle>
                  <JournalTitle>Am J Vet Res</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>581</FirstPage>
                  <LastPage>588</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15900936</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2460/ajvr.2005.66.581</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjvVWmtbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bennett N, Papich MG, Hoenig M, Fettman MJ, Lappin MR. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats.<Emphasis Type="Italic">Am J Vet Res</Emphasis>. 2005;66:581–588.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ciribassi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Luescher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KS</Initials>
                    <FamilyName>Pasloske</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Robertson-Plouch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Zimmerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Kaloostian-Whittymore</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats</ArticleTitle>
                  <JournalTitle>Am J Vet Res</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>994</FirstPage>
                  <LastPage>998</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12926591</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2460/ajvr.2003.64.994</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmslamtrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ciribassi J, Luescher A, Pasloske KS, Robertson-Plouch C, Zimmerman A, Kaloostian-Whittymore L. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.<Emphasis Type="Italic">Am J Vet Res</Emphasis>. 2003;64:994–998.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibUnstructured>Trepanier LA. Transdermal formulations: which ones are effective? ACVIM Annual Forum Proceedings; June 2002; American College of Veterinary Medicine. 463–464.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LL</Initials>
                    <FamilyName>Sartor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Trepanier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Kroll</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Rodan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Challoner</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism</ArticleTitle>
                  <JournalTitle>J Vet Intern Med</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>651</FirstPage>
                  <LastPage>655</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15515580</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1892/0891-6640(2004)18&lt;651:EASOTM&gt;2.0.CO;2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sartor LL, Trepanier LA, Kroll MM, Rodan I, Challoner L. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism.<Emphasis Type="Italic">J Vet Intern Med</Emphasis>. 2004.18(5):651–655.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Taboada</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Topical methimazole treatment of cats with hyperthyroidism</ArticleTitle>
                  <JournalTitle>J Vet Intern Med</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>299</FirstPage>
                  <LastPage>299</LastPage>
                </BibArticle>
                <BibUnstructured>Hoffman G, Marks SL, Taboada J, et al. Topical methimazole treatment of cats with hyperthyroidism.<Emphasis Type="Italic">J Vet Intern Med</Emphasis>. 2001;15:299.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Mealey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Peck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BS</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats</ArticleTitle>
                  <JournalTitle>J Vet Intern Med</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>43</FirstPage>
                  <LastPage>46</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14765730</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1892/0891-6640(2004)18&lt;43:SAOAAB&gt;2.0.CO;2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD2c%2FmsVGrsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mealey KL, Peck KE, Bennett BS, et al. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.<Emphasis Type="Italic">J Vet Intern Med</Emphasis>. 2004; 18(1):43–46.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HS</Initials>
                    <FamilyName>Willis-Goulet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Schmidt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CF</Initials>
                    <FamilyName>Nicklin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study</ArticleTitle>
                  <JournalTitle>Vet Dermatol</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>83</FirstPage>
                  <LastPage>89</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12662265</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-3164.2003.00331.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Willis-Goulet HS, Schmidt BA, Nicklin CF, et al. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.<Emphasis Type="Italic">Vet Dermatol</Emphasis>. 2003;14:83–89.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibChapter>
                  <InstitutionalAuthorName>United States Pharmacopeial Convention</InstitutionalAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Pharmaceutical compounding</ChapterTitle>
                  <BookTitle>The United States Pharmacopeia and the National Formulary, USP 28, NF 23</BookTitle>
                  <PublisherName>United States Pharmacopeial Convention Inc</PublisherName>
                  <PublisherLocation>Rockville, MD</PublisherLocation>
                  <FirstPage>795</FirstPage>
                  <LastPage>795</LastPage>
                </BibChapter>
                <BibUnstructured>United States Pharmacopeial Convention. Pharmaceutical compounding. In: The United States Pharmacopeia and the National Formulary, USP 28, NF 23. Rockville, MD: United States Pharmacopeial Convention Inc; 2005:&lt;795&gt;, &lt;797&gt;,&lt;1075&gt;.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
